[1] |
YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun.
Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk
[J]. China Oncology, 2021, 31(9): 828-837.
|
[2] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[3] |
ZHANG Yingqiang , LIN Yansong .
Application and research progress of 90 Y microspheres internal radiation therapy in colorectal cancer with liver metastasis
[J]. China Oncology, 2021, 31(8): 762-768.
|
[4] |
XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia.
The advances in immunotherapy biomarkers of small cell lung cancer
[J]. China Oncology, 2021, 31(7): 635-639.
|
[5] |
LI Wei, ZHANG Shanling, TAO Yingjie, WANG Xudong.
Research status and progress of mechanism of T cell immune metabolism and its application combined with immune checkpoint inhibitor
[J]. China Oncology, 2021, 31(7): 640-646.
|
[6] |
ZHENG Peiming , LI Junmeng , ZHANG Peng , GAO Lan .
Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer
[J]. China Oncology, 2021, 31(5): 368-378.
|
[7] |
PENG Zishan, KONG Hui, BAO Zhen, ZHAO Hongxing, LIU Xin, LU Shaohua.
Clinicopathological analysis of 83 cases of multifocal lung adenocarcinoma
[J]. China Oncology, 2021, 31(5): 408-418.
|
[8] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[9] |
ZHU Jun, WU Xiaohua.
Leading research progress and prospect of gynecological oncology in 2020
[J]. China Oncology, 2021, 31(4): 250-256.
|
[10] |
ZHU Junjun, GE Naijian, YANG Yefa.
Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor
[J]. China Oncology, 2021, 31(4): 257-262.
|
[11] |
LI Ruixiao , TANG Qisheng , MA Shanjin , ZHANG Bo , LI Xuelian , ZHANG Zhiming .
NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression
[J]. China Oncology, 2021, 31(4): 263-267.
|
[12] |
LIU Bin , ZHENG Pengyuan , MI Yang , REN Feifei , GAO Shuang , LIU Chuan , LI Fazhan .
Expression of LRP8 in gastric cancer and its significance in tumorigenesis
[J]. China Oncology, 2021, 31(4): 285-293.
|
[13] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|
[14] |
CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin.
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
[J]. China Oncology, 2021, 31(4): 330-334.
|
[15] |
YU Li , SHEN Minna , JIANG Huiqin , WANG Beili , GUO Wei .
The progress and prospect of homologous recombination deficiency detection in clinical diagnosis and treatment of cancer
[J]. China Oncology, 2021, 31(4): 344-349.
|